Cross-institution positioning
Mar 27, 2026Reduction leaning. 4 reducing across 4 comparable institutions.
Source: Schedule 13 researchSee how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Reduction leaning. 4 reducing across 4 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 2 purchases by 2 reporting owners and 0 sales by 0 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/52 non-amendment material events in the last 90 days; Latest classified evidence: Shareholder vote results. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +1.1% YoY; Net income +234.4% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 3% through its reported 52-week range; -13.6% over one year.
Source: Stored historical price seriesFiled Mar 27, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Carucci Richard | AGrant, award, or other acquisition · derivative | Phantom Stock-d | 5.3K | $14.15 | Direct | Sep 29, 2026 |
| Sep 25, 2026 | Shattock Matthew J | AGrant, award, or other acquisition · derivative | Phantom Stock-d | 2.2K | $14.15 | Direct | Sep 29, 2026 |
| Sep 25, 2026 | HOPLAMAZIAN MARK SAMUEL | AGrant, award, or other acquisition · derivative | Phantom Stock-d | 1.8K | $14.15 | Direct | Sep 29, 2026 |
| Aug 13, 2026 | Carucci Richard | POpen-market or private purchase | Common Stock | 20.0K | $14.73 | Direct | Aug 17, 2026 |
| Jul 31, 2026 | Darrell Bracken | POpen-market or private purchase | Common Stock | 32.9K | $14.98 | Direct | Aug 3, 2026 |
| Jun 26, 2026 | Shattock Matthew J | AGrant, award, or other acquisition · derivative | Phantom Stock-d | 1.8K | $17.37 | Direct | Jun 30, 2026 |
| Jun 26, 2026 | HOPLAMAZIAN MARK SAMUEL | AGrant, award, or other acquisition · derivative | Phantom Stock-d | 1.4K | $17.37 | Direct | Jun 30, 2026 |
| Jun 26, 2026 | Carucci Richard | AGrant, award, or other acquisition · derivative | Phantom Stock-d | 4.3K | $17.37 | Direct | Jun 30, 2026 |
| Jun 9, 2026 | Carucci Richard | POpen-market or private purchase | Common Stock | 30.0K | $17.17 | Direct | Jun 10, 2026 |
| Jun 4, 2026 | Phillips Michael Edward | FTax/price withholding or payment | Common Stock | 1.6K | $16.41 | Direct | Jun 8, 2026 |
| Jun 4, 2026 | Sim Jennifer S. | FTax/price withholding or payment | Common Stock | 4.1K | $16.41 | Direct | Jun 8, 2026 |
| Jun 4, 2026 | Hyder Brent | FTax/price withholding or payment | Common Stock | 20.4K | $16.41 | Direct | Jun 8, 2026 |
| Jun 4, 2026 | Darrell Bracken | FTax/price withholding or payment | Common Stock | 36.4K | $16.41 | Direct | Jun 8, 2026 |
| Jun 4, 2026 | Vogel Paul Aaron | FTax/price withholding or payment | Common Stock | 10.2K | $16.41 | Direct | Jun 8, 2026 |
| Jun 4, 2026 | Dalmia Abhishek | FTax/price withholding or payment | Common Stock | 11.4K | $16.41 | Direct | Jun 8, 2026 |
| May 28, 2026 | Phillips Michael Edward | FTax/price withholding or payment | Common Stock | 941 | $17.41 | Direct | Jun 1, 2026 |
| May 28, 2026 | Dalmia Abhishek | FTax/price withholding or payment | Common Stock | 36.8K | $17.41 | Direct | Jun 1, 2026 |
| May 22, 2026 | Vogel Paul Aaron | AGrant, award, or other acquisition · derivative | FY 2027 Non-qualified Stock Option (Right to Buy) | 149.3K | $0.00 | Direct | May 27, 2026 |
| May 22, 2026 | Vogel Paul Aaron | AGrant, award, or other acquisition | Common Stock | 107.8K | $16.70 | Direct | May 27, 2026 |
| May 22, 2026 | GROSSMAN MINDY F | AGrant, award, or other acquisition | Common Stock | 12.0K | $16.70 | Direct | May 27, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Jul 30, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| Jul 29, 2026 | 8-K | 2.02, 5.02, 7.01, 9.01 | Results of operations / financial condition; Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| May 20, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jan 28, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Jan 28, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jan 8, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Nov 12, 2025 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Oct 28, 2025 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 27, 2025 | $2.9B | +1.5% |
| Ended Sep 27, 2025 | $2.8B | +1.6% |
| Ended Jun 28, 2025 | $1.8B | -0.5% |
| Ended Dec 28, 2024 | $2.8B | +1.9% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Mar 28, 2026 | $9.6B | +1.1% |
| Ended Mar 29, 2025 | $9.5B | -4.1% |
| Ended Mar 30, 2024 | $9.9B | -10.6% |
| Ended Apr 1, 2023 | $11.1B | -6.4% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Reported reduction | 11 -37.3M | 12.00% +2.47 pts | $15.96 | $16.40 | $15.00 |
| Vanguard Group CIK0000102909 | Sep 30, 2025 observed Oct 31, 2025 filed · 31d Schedule 13G amendment | Reported reduction | 37.3M -3.8M | 9.53% -1.03 pts | $14.43 | $14.04 | $15.00 |
| BlackRock CIK0002012383 | Mar 31, 2025 observed Apr 17, 2025 filed · 17d Schedule 13G amendment | Earliest Schedule 13G amendment found | 28.9M | 7.40% | $15.52 | $10.45 | $15.00 |
Compare VFC with other securities showing similar institutional activity or recent accumulation across several tracked institutions.